Peptide Receptor Radiotherapy as a Potential Tool of Neoadjuvant Therapy in Patients with Inoperable Neuroendocrine Tumors (NETs)

被引：0
|
作者：
Sowa-Staszczak, A. [1 ]
Pach, D. [1 ]
Stefanska, A. [1 ]
Tomaszuk, M. [1 ]
Mikolajczak, R. [2 ]
Pawlak, D. [2 ]
Trofimiuk, M. [1 ]
Chrzan, R. [3 ]
Hubalewska-Dydejczyk, A. [1 ]
机构：
[1] Jagiellonian Univ, Nucl Med Unit, Dept Endocrinol, Coll Med, Otwock, Poland
[2] IAE Radioisotope Ctr POLATOM, Otwock, Poland
[3] Jagiellonian Univ, Dept Radiol, Coll Med, Krakow, Poland
来源：
NEUROENDOCRINOLOGY | 2011年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] Key device attributes for Somatostatin Receptor Ligand (SRL) therapy in patients with neuroendocrine tumors (NETs)
    Martin, W.
    Kolarova, T.
    Marks, M.
    Follin, C.
    de Herder, W.
    Geilvoet, W.
    Jorgensen, J. O. L.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 232 - 232
  • [42] A single institution experience with peptide receptor radionuclide therapy (PRRT) in non-midgut neuroendocrine tumors (NETs)
    Duan, H.
    Ferri, V
    Fisher, G.
    Shaheen, S.
    Davidzon, G.
    Moradi, F.
    Nguyen, J.
    Franc, B.
    Iagaru, A.
    Mari, Aparici C.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 181 - 181
  • [43] Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS)
    Badawy, Mohmed
    Johnson, Geoffrey B.
    Hobday, Timothy
    Packard, Annie T.
    Jain, Manoj
    Halfdanarson, Thorvardur R.
    Young, Jason R.
    Thorpe, Matthew P.
    Eiring, Rachel A.
    Kendi, Ayse Tuba
    [J]. PANCREAS, 2022, 51 (03) : E42 - E42
  • [44] Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma
    Opalinska, Marta
    Sowa-Staszczak, Anna
    Al Maraih, Ibraheem
    Gilis-Januszewska, Aleksandra
    Hubalewska-Dydejczyk, Alicja
    [J]. BIO-ALGORITHMS AND MED-SYSTEMS, 2021, 17 (04) : 221 - 226
  • [45] Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours
    Prospero, I.
    Ferreira, G.
    Ferro, J. C.
    Barbosa, D.
    Silva, D. G.
    Fontao de Castro, S.
    Teixeira, J. P.
    Duarte, H.
    Lucena Sampaio, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S220 - S220
  • [46] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    [J]. NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [47] Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors
    Lo Russo, Giuseppe
    Pusceddu, Sara
    Prinzi, Natalie
    Imbimbo, Martina
    Proto, Claudia
    Signorelli, Diego
    Vitali, Milena
    Ganzinelli, Monica
    Maccauro, Marco
    Buzzoni, Roberto
    Seregni, Ettore
    de Braud, Filippo
    Garassino, Marina Chiara
    [J]. TUMOR BIOLOGY, 2016, 37 (10) : 12991 - 13003
  • [48] Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Delbeke, Dominique
    Graham, Michael M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 663 - 663
  • [49] Quality Of Life in Patients with Neuroendocrine Gastroenteropancreatic Tumors Treated with Peptide Receptor Radionuclide Therapy
    Georgakopoulos, A.
    Liotsou, T.
    Chatziioannou, S. N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S691 - S691
  • [50] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    [J]. BLOOD, 2020, 136
12345